Betamethasone Ointment Market

Global Betamethasone Ointment Market Size, Share and Trends Analysis Report, By Type (Betamethasone Dipropionate, Betamethasone Sodium Phosphate, and Betamethasone Valerate), Forecast (2021-2027)
    Update Available - Forecast 2024-2030   

Published: Jul 2023 | Report Code: OMR2025823 | Category : Pharmaceuticals | Delivery Format: /

The global betamethasone ointment market is anticipated to grow at a significant CAGR during the forecast period (2021-2027). The major factors that are expected to boost the market during the forecast period include increasing incidences of skin disorders such as psoriasis, rising incidences of asthma, surge in cancer patients, and rising incidences of rheumatoid disorders such as rheumatoid arthritis and systemic lupus erythematosus. Betamethasone topical is used to treat the itching, redness, dryness, crusting, scaling, inflammation, and discomfort of various skin conditions, including psoriasis (a skin disease in which red, scaly patches form on some areas of the body) and eczema (a skin disease that causes the skin to be dry and itchy and to sometimes develop red, scaly rashes). 

Betamethasone belongs to a class of medications called corticosteroids. It works by activating natural substances in the skin to reduce swelling, redness, and itching. Furthermore, the advent of different formulations of betamethasone and untapped market opportunities in emerging nations will further boost the market growth. In order to maintain a strong position in the market, these market players are adopting various strategic moves, such as product launches, partnerships and collaborations, and mergers and acquisitions. For instance, in March 2020, Lupin Ltd. declared the launch of Betamethasone Dipropionate Ointment USP (Augmented), 0.05%, having received an approval from the US Food and Drug Administration (US FDA) earlier. The product would be manufactured at Lupin’s Pithampur (Unit III) facility, India. It is the generic equivalent of Diprolene Ointment, 0.05%, of Merck Sharp and Dohme Corp. It is a corticosteroid indicated for the relief of the inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses in patients 13 years of age and older.

Market Coverage

    • The market number available for – 2020-2027

    • Base year- 2020

    • Forecast period- 2021-2027

    • Segment Covered- 

o By Type 

Regions covered-

o North America

o Europe

o Asia-Pacific

o Rest of the World

  • Competitive Landscape: GlaxoSmithKline plc, Merck & Co., Inc., and Cipla Inc., among others. 

Key questions addressed by the report

    • What is the market growth rate?

    • Which segment and region dominate the market in the base year?

    • Which segment and region will project the fastest growth in the market?

    • How has COVID-19 impacted the market?

o Deviation from the pre-COVID-19 forecast

o Most affected region and segment

    • Who is the leader in the market?

    • How are players addressing challenges to sustain growth?

    • Where is the investment opportunity?

Global Betamethasone Ointment Market Report by Segment

By Type

    • Betamethasone Dipropionate

    • Betamethasone Sodium Phosphate

    • Betamethasone Valerate

Global Betamethasone Ointment Market Report by Region

North America       

    • US

    • Canada

Europe

    • Germany

    • UK

    • France

    • Spain

    • Italy

    • Rest of Europe

Asia-Pacific    

    • China

    • Japan

    • India

    • Rest of Asia-Pacific

Rest of the World

    • Latin America

    • Middle East and Africa